Sickle Cell Cured: The First CRISPR Miracle
For most of human history, sickle cell disease was managed, not cured. In 2023, CRISPR changed that. The first approved gene-editing therapy edits a patient's own bone marrow stem cells, reactivating fetal hemoglobin genes silenced after birth. The cells work normally. The disease stops.